Two Sigma Advisers’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-97,332
Closed -$724K 332
2025
Q4
$724K Buy
97,332
+400
+0.4% +$2.88K ﹤0.01% 1641
2025
Q3
$648K Buy
96,932
+81,200
+516% +$564K ﹤0.01% 1658
2025
Q2
$104K Buy
15,732
+3,700
+31% +$26.2K ﹤0.01% 2204
2025
Q1
$110K Sell
12,032
-400
-3% -$4K ﹤0.01% 2230
2024
Q4
$131K Sell
12,432
-1,000
-7% -$11.8K ﹤0.01% 2186
2024
Q3
$161K Sell
13,432
-78,100
-85% -$675K ﹤0.01% 2112
2024
Q2
$526K Sell
91,532
-49,700
-35% -$273K ﹤0.01% 1858
2024
Q1
$734K Buy
141,232
+13,300
+10% +$65K ﹤0.01% 1713
2023
Q4
$674K Buy
127,932
+78,400
+158% +$310K ﹤0.01% 1804
2023
Q3
$163K Buy
49,532
+27,500
+125% +$96.5K ﹤0.01% 2135
2023
Q2
$63.7K Sell
22,032
-12,400
-36% -$23.8K ﹤0.01% 2249
2023
Q1
$36.8K Buy
+34,432
New +$65.9K ﹤0.01% 2479
2022
Q3
Sell
-10,132
Closed -$69K 2562
2022
Q2
$69K Sell
10,132
-700
-6% -$7.14K ﹤0.01% 2440
2022
Q1
$153K Sell
10,832
-2,197
-17% -$29.4K ﹤0.01% 2427
2021
Q4
$189K Sell
13,029
-16,171
-55% -$230K ﹤0.01% 2299
2021
Q3
$413K Buy
29,200
+19,200
+192% +$295K ﹤0.01% 1999
2021
Q2
$176K Buy
+10,000
New +$161K ﹤0.01% 2284

Other funds holding BVS

Two Sigma Advisers's BVS Position: Q1 2026 in Review

Two Sigma Advisers sold out of Bioventus (BVS) in Q1 2026, closing a stake of 97,332 shares — an estimated $724K sold.

Two Sigma Advisers first reported a position in BVS in Q2 2021 and held it in 17 quarters. The position peaked at $734K in Q1 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.

  • Two Sigma Advisers reported no remaining Bioventus position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 97,332 Bioventus shares in Q1 2026, an estimated $724K.
  • Two Sigma Advisers first reported a position in Bioventus in Q2 2021 and held it in 17 quarters.
  • Two Sigma Advisers's Bioventus position peaked at $734K in Q1 2024.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.